Citadel Advisors’s NRX Pharmaceuticals NRXP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Buy |
+92,361
| New | +$301K | ﹤0.01% | 4615 |
|
|
2025
Q1 | – | Hold |
0
| – | – | – | 6637 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6509 |
|
|
2024
Q3 | – | Hold |
0
| – | – | – | 6404 |
|
|
2024
Q2 | – | Hold |
0
| – | – | – | 6531 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6631 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6419 |
|
|
2023
Q3 | – | Sell |
-25
| Closed | -$119 | – | 6287 |
|
|
2023
Q2 | $119 | Hold |
25
| – | – | ﹤0.01% | 5716 |
|
|
2023
Q1 | $163 | Sell |
25
-1,231
| -98% | -$8.03K | ﹤0.01% | 5826 |
|
|
2022
Q4 | $13.9K | Buy |
+1,256
| New | +$13.9K | ﹤0.01% | 5623 |
|
|
2022
Q3 | – | Sell |
-9,167
| Closed | -$55K | – | 6431 |
|
|
2022
Q2 | $55K | Buy |
+9,167
| New | +$55K | ﹤0.01% | 5471 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 6869 |
|
|
2021
Q4 | – | Sell |
-13,509
| Closed | -$1.25M | – | 6934 |
|
|
2021
Q3 | $1.25M | Buy |
+13,509
| New | +$1.25M | ﹤0.01% | 3523 |
|